Skip to main content
Premium Trial:

Request an Annual Quote

Alessandra Cesano

NanoString Technologies has named Alessandra Cesano its chief medical officer. Cesano brings more than 25 years of experience in drug development, diagnostics, and cancer immunology.

Cesano comes to NanoString from Cleave Biosciences where she served as CMO. She was also CMO and chief operations officer at Nodality. Prior to Nodality, she held various management positions at Biogen Idec, Amgen, and SmithKline Beecham Pharmaceuticals, and positions in academia and tumor immunology research.

Cesano's credentials include an MD, a board certification in oncology, and a PhD in tumor immunology from the University of Turin. She is also a member of the American Association for Cancer Research, the American Society of Clinical Oncology, the American Society of Hematology, the European Hematologic Association, and the Society for Immunotherapy of Cancer.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.